Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Solid Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Foghorn Therapeutics Inc. June 17, 202589.2%
-
Solid Biosciences Inc. June 7, 202472.6%
-
Stoke Therapeutics Inc. June 5, 202498.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | Solid Biosciences Inc. | Option exercise | +3,440 | — | — |
| Jul 2, 2026 | Solid Biosciences Inc. | Option exercise | +3,440 | — | — |
| Apr 2, 2026 | Solid Biosciences Inc. | Option exercise | +3,441 | — | — |
| Jan 6, 2026 | Solid Biosciences Inc. | Option exercise | +4,573 | — | — |
| Oct 6, 2025 | Solid Biosciences Inc. | Option exercise | +4,573 | — | — |
| Jul 6, 2025 | Solid Biosciences Inc. | Option exercise | +4,573 | — | — |
| Apr 6, 2025 | Solid Biosciences Inc. | Option exercise | +4,574 | — | — |
| Jan 3, 2025 | Solid Biosciences Inc. | Option exercise | +3,255 | — | — |
| Oct 3, 2024 | Solid Biosciences Inc. | Option exercise | +3,255 | — | — |
| Jul 3, 2024 | Solid Biosciences Inc. | Option exercise | +3,255 | — | — |
| Apr 3, 2024 | Solid Biosciences Inc. | Option exercise | +3,256 | — | — |
| Jan 3, 2024 | Solid Biosciences Inc. | Option exercise | +15,570 | — | — |
| Oct 3, 2023 | Solid Biosciences Inc. | Option exercise | +15,569 | — | — |
| Jul 3, 2023 | Solid Biosciences Inc. | Option exercise | +15,570 | — | — |
| Apr 3, 2023 | Solid Biosciences Inc. | Option exercise | +15,569 | — | — |
Questions about Ian F. Smith
What boards is Ian F. Smith on?
Ian F. Smith sits on the boards of Foghorn Therapeutics Inc., Odyssey Therapeutics Inc., Solid Biosciences Inc. and Stoke Therapeutics Inc.
What company is Ian F. Smith the CEO of?
Ian F. Smith is Interim CEO of Stoke Therapeutics Inc.
How long has Ian F. Smith served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.